Detail akcie Sensus Healthcar Rg online

Business Summary: Sensus Healthcare, Inc. is a medical device company that is engaged in the development and delivery of non-invasive treatments for skin cancer and keloids. The Company, leveraging its superficial radiotherapy (SRT and IG-SRT) technology, provides healthcare providers with a patient-centric treatment platform. Its products and services include SRT-100, SRT-100 Vision, SRT-100+, Sentinel service program and others. The SRT-100 is a photon x-ray low energy SRT system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers and other skin conditions such as keloids. The SRT-100 Vision provides customers with additional options compared to the SRT-100 base model. These additional options allow for dedicated treatment planning and full treatment progression documentation in a patient’s record. The SRT-100+ offers all the same features as the SRT-100, with the addition of remote diagnostics and other features.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Sensus Healthcare Inc revenues decreased 22% to $22.5M. Net loss totaled $4.6M vs. income of $5.1M. Revenues reflect Product Revenue segment decrease of 28% to $18.1M, United States segment decrease of 24% to $21.3M. Net loss reflects Research and development increase from $2.7M to $5.9M (expense), Selling and marketing increase of 43% to $5.1M (expense).